10/06/2020 08:45 AM
- 10/06/2020 09:00 AM
Tomislav Mihaljevic, MD, CEO & President, Cleveland Clinic
Will Morris, MD, Executive Medical Director, Innovations, Cleveland Clinic
10/06/2020 09:00 AM
- 10/06/2020 09:45 AM
COVID-19 put a strain and a spotlight on healthcare executives worldwide – while no system was too big to avoid impact, no system was too small to make one either. Faced with a crisis, these entities demonstrated the revolutionary power that collective efforts have on our ability to care for patients. The lofty goal of better, faster, widespread care became a reality as all systems did what they could to ensure community health. Join us as experts from world-renowned provider systems detail the current state of collaboration in healthcare – as influenced by its recent past – and impart their strategic visions for its secure place in the future.
Moderator: Joan Lunden, Journalist, Bestselling Author, Motivational
Gianrico Farrugia, MD, President & CEO, Mayo Clinic
Anne Klibanski, MD, President & CEO, Mass General Brigham
Tomislav Mihaljevic, MD, CEO and President, Cleveland Clinic
10/06/2020 09:45 AM
- 10/06/2020 10:35 AM
As a result of the COVID-19 pandemic, the world of healthcare investment has been turned on its head. Uncertain times have skilled investors looking to protect their existing projects and shying away from riskier, up-and-coming technologies. Innovative startups, already strapped for cash, find themselves in a bind. What processes are investors implementing to return their support to these small businesses? In the market, what investment opportunities have revealed themselves for better preparedness in the future?
Moderator: Lydia Ramsey Pflanzer, Healthcare Editor, Business Insider
Joe Cunningham, MD, Founding Managing Partner, Santé Ventures
Mudit Jain, PhD, Founder & General Partner, Strategic Healthcare Investment Partners
Alexis Ji, PhD, Partner, Illumina Ventures
Dave Neustaedter, Vice President, Venture Capital, Medtronic
Kristina Simmons, Chief of Staff, Khosla Ventures
10/06/2020 10:35 AM
- 10/06/2020 11:05 AM
Telemedicine has revolutionized care in 2020 – allowing patients and providers to stay connected through technology. All ecosystem players have made fundamental shifts to establish virtual care as a suitable, sustainable alternative. How did payors elevate their telehealth services to levels that far exceed those pre-COVID? How has accelerated payor-provider collaboration played a role? What’s a payor’s plan for clear, accessible virtual care when the situation is no longer deemed a threat?
Moderator: Tomislav Mihaljevic, MD, CEO & President, Cleveland Clinic
Gail Boudreaux, President & CEO, Anthem, Inc
10/06/2020 11:20 AM
- 10/06/2020 12:00 PM
Social media platforms, wearable fitness trackers, and other connected medical devices are revolutionizing patient care with their ability to diagnose, monitor, and even treat through data. But the patient data held in these digital systems are governed by laws that predate most online and mobile services utilized today. Without clear and current policy guardrails, we are unable to realize digital health’s full potential. The digital healthcare and data privacy initiatives must merge lanes to drive toward practical, protected patient data.
Moderator: Jim Young, MD, Chief Academic Officer, Cleveland Clinic
Jacqueline Law, PhD, Global Head, Personalized Healthcare Data Science, Roche/ Genentech
Tom Lawry, National Director of AI for Health & Life Sciences, Microsoft
Paul Muret, VP Product & Engineering, Google
Don Trigg, President, Cerner
10/06/2020 12:05 PM
- 10/06/2020 12:45 PM
Healthcare’s best CIOs have been planning for new and improved models of care delivery in accordance with digital trends for years. Yet nearly overnight, technologies like telemedicine and remote monitoring became staples for our healthcare providers. Though demanding a level of digital safety and efficacy we hadn’t anticipated for 2-5 years, this period has forever changed the way we embrace innovation in healthcare. How were health systems able to bring these programs to fruition in a pinch? What are they doing now to ensure we make the most of these revolutionary tools moving forward?
Moderator: Chrissy Farr, Reporter, CNBC
Alistair Erskine, MD, Chief Digital Health Officer, Partners Healthcare
Matt Kull, CIO, Cleveland Clinic
Angela Yochem, Chif Digital & Technology Officer, Novant Health
Richard Zane, MD, Chief Innovation Officer, UCHealth
10/06/2020 13:00 PM
- 10/06/2020 13:05 PM
Herbert Wiedemann, MD, Chief of Staff, Cleveland Clinic
10/06/2020 13:05 PM
- 10/06/2020 13:35 PM
The defining feature of a pandemic, COVID-19 has affected those in all corners of the world. From European suburbs to major U.S. cities, sick patients everywhere are seeking care for the novel, alarming virus. With so many undergoing treatment in such a rapid timeframe and emerging stigmas regarding its transmission, patient safety and patient-centered healthcare are at risk of falling by the wayside. In this fireside chat, hear from some international minds as they ideate to ensure these principles remain a top priority industry-wide.
Moderator: Brian Donley, MD, CEO, Cleveland Clinic London
Mace Rothenberg, MD, CMO, Pfizer
10/06/2020 13:40 PM
- 10/06/2020 14:20 PM
In times of crisis, teamwork and collaboration aren’t values to be taken lightly. Often joint efforts provide more opportunities for success and movement of the needle. Faced with enormous pressures as a result of COVID-19, the pharmaceutical industry joined forces to strengthen its response. Here pharma execs will discuss the creative, collaborative, and expedited development processes put in place to quickly advance and scale lifesaving compounds.
Moderator: Meg Tirrell, Senior Health & Science Reporter, CNBC
Stéphane Bancel, CEO, Moderna
Rajeev Venkayya, MD, President of the Global Vaccine Business Unit,Takeda Pharmaceutical Company
Pampee Young, MD, PhD, Chief Medical Officer, Biomedical Services, American Red Cross
10/06/2020 14:25 PM
- 10/06/2020 15:05 PM
With business models and production plans overhauled by the extreme need for healthcare PPE, medical device companies and supply chain professionals found themselves calling for innovative solutions from some unconventional enterprises. Industries like toy and auto were quick to pivot manufacturing efforts and answer the siren call. With this panel, understand the mental and physical changes enacted by these executive humanitarians to bring safe, effective supplies to those on the frontline.
Susan Brennan, COO, Bloom Energy
Michelle Nadeau, Chief Marketing Officer, Timbuk2
Simrit Sandhu, Chief Supply Chain & Support Services Officer, Cleveland Clinic
Eric Walli, Associate Chief Advisor, Regional Planning Division Manager American Honda Motor, Inc.
Heath Rigsby is Vice President and Commercial Leader of the Out of Home business for The Clorox Company, a leading multinational manufacturer and marketer of consumer and professional products with about 8,800 employees worldwide and sales of $6.7 billion.
Since joining Clorox in 2001, Heath has held domestic and international sales, marketing and general management positions in both the consumer and professional markets including most recently Vice President of International Sales and Vice President of Professional Products Sales. In his current role, Heath leads the newly formed Clorox Out of Home group, a multi-functional team charged with building alliances and partnerships with global multinational organizations.
Prior to joining Clorox, Heath worked for Procter & Gamble. He has an M.B.A. from the University of Tennessee and a B.S. from The University of North Carolina at Chapel Hill.
Dr. Moshe Ornstein is a genitourinary medical oncologist at the Cleveland Clinic Taussig Cancer Institute. He attended Columbia University for graduate school, where he received a degree in biotechnology. Following graduate school, he attended medical school at SUNY Stony Brook. His completed his internal medicine residency and hematology/oncology fellowship at the Cleveland Clinic.
Dr. Ornstein's clinical practice and research are focused on cancers of the genitourinary system, with a particular emphasis clinical trial development and drug discovery. His research has been presented at numerous scientific meetings and published in high impact journals such as the The Journal of Clinical Oncology and The Lancet Oncology.
Mr. Glass is the Chief Financial Officer of the Cleveland Clinic. He joined the Cleveland Clinic in 2002 as the Controller and Chief Accounting Officer and served in that role until 2005, when he assumed his current role. Mr. Glass is responsible for all financial operations of the Cleveland Clinic Health System which includes eleven owned hospitals and two managed hospitals, and over 3,000 employed physicians in the Cleveland Clinic Medical Group. The Clinic has operations in Ohio, Florida, Nevada, Canada, and the United Arab Emirates.
Prior to joining the Cleveland Clinic, Mr. Glass was the Vice President of Finance for MedStar Health, where he spent fourteen years serving in various roles during its growth through mergers and acquisitions during the mid-nineties.
Mr. Glass received a Bachelor of Science degree in Accounting from Towson University and is a Certified Public Accountant. He is a member of the American Institute of Certified Accountants, Ohio Society of Certified Public Accountants, Healthcare Financial Management Association, Health Management Academy, and a Board Member of the Ohio Hospital Association.
Steven M. Gordon, MD, Chairman and Staff Member in the Department of Infectious Disease and a Staff Member in the Transplantation Center.
He is certified in Internal Medicine, as well as Infectious Disease by the American College of Physicians. His specialty interests include healthcare epidemiology, infective endocarditis, and cardiac device infections
Dr. Gordon earned his medical degree from Cornell University Medical College in New York. He completed an internship and residency in Internal Medicine at the University of Chicago Hospitals and Clinics in Chicago, as well as a residency with the U.S. Public Health Service. He was a Fellow with the Centers for Disease Control, Hospital Infections Program, as well as a Fellow with Emory University Hospital in Atlanta, Ga.
He is a member of several professional organizations, including the Society Healthcare Epidemiology of America for which served as President of the society (January 2011). He is a Fellow of the Infectious Disease Society of America, a Fellow of the American College of Physicians, and member of American Society of Transplantation. Dr. Gordon has received a number of honors and awards over the years. Most recently, he was appointed to serve on the Defense Health Board which serves as a Federal Advisory Committee to the Secretary of Defense. He has also presented a number of national and international meetings, as well as having published more than 160 articles and multiple book chapters.